High Risk Percutaneous Coronary Intervention
9 clinical trials · Condition
◉ Watch High Risk Percutaneous Coronary Intervention
| Record | Firm | Date |
|---|---|---|
| Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients (NCT06099548) | Magenta Medical Ltd. | 2020-12-17 |
| Impella ECP Early Feasibility Study (NCT04477603) | Abiomed Inc. | 2020-10-09 |
| Protect Kidney Trial (NCT04321148) | Heinrich-Heine University, Duesseldorf | 2020-01-24 |
| HeartMate PHP™ CE Mark Clinical Investigation Plan (NCT02156609) | Abbott Medical Devices | 2014-06-01 |
Track High Risk Percutaneous Coronary Intervention automatically
Every clearance here is in the API, with alerts when new ones post.